NCT00118170
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +83 more
- Locations
-
- Cancer and Leukemia Group B (CALGB) Research Base Chicago, Illinois, United States
Clinical trial condition
Splenic Marginal Zone Lymphoma
Explore clinical trials studying Splenic Marginal Zone Lymphoma. Study availability and eligibility vary by location and protocol.
98 public trials
3 recruiting studies
Splenic Marginal Zone Lymphoma trial results
NCT00799461
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +154 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +136 more
- Locations
-
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
Active, Not Recruiting
Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma
NCT01479842
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, +29 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
Active, Not Recruiting
Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL Patients
NCT05735834
- Conditions
- Splenic Marginal Zone Lymphoma
- Locations
-
- Medical University of Vienna Vienna, Austria
- Institut Bergonié Bordeaux, France
- CHU de Grenoble Grenoble, France
- Hôpital Saint Louis Paris, France
Active, Not Recruiting
Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma
NCT01815749
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Blood Protein Disorders, Burkitt Lymphoma, +64 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, Not Recruiting
MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas
NCT03697512
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- CHU UCL Namur / site Godinne Yvoir, Belgium
- CHU de Tours - Hôpital Bretonneau Tours, Cedex 01, France
- CHU de Montpellier Montpellier, Cedex 05, France
- CHU d'Estaing Clermont-Ferrand, Cedex 1, France
Active, Not Recruiting
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
NCT01199562
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +245 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States